Follow-up after testicular cancer surgery and chemotherapy
Part of Cancer, Hormones & metabolism, Kidney & urinary clinical trials.
This study looks at how people should be followed after treatment for testicular cancer (surgery and, for some, chemotherapy). It may help improve follow-up plans while keeping an eye out for cancer coming back.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older.
- You were treated with curative (aimed at cure) surgery less than 3 months ago, or you completed chemotherapy and are in complete remission.
- Your blood “tumor marker” tests are normal for three checks in a row.
- Scans after treatment show no spread to lymph nodes or distant sites.
- Your LDH blood test was not unusually high before surgery (LDH must be 248 U/L or less).
- You can complete the study’s questionnaires and you can read Dutch well enough.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how testicular cancer and its treatments affect your quality of life and daily function. Researchers want to learn more about the long-term outcomes of surgery so they can better support patients like you.
This study compares two standard treatments—surgery to remove lymph nodes in the abdomen (RPLND) versus chemotherapy—for men with testicular cancer that has spread to a small area in the abdomen. The goal is to see which approach works better and has fewer side effects.
This study looks at heart health in men who have survived testicular cancer. It compares those who had different treatments (surgery, chemotherapy, or chemotherapy plus a stem cell transplant) to see if there are hidden signs of heart or blood vessel problems.
This study looks at fertility outcomes in young men who had cancer or blood disorders as children and then received high-risk treatment that can affect future fertility. It also compares people who did or did not store testicular tissue through a biopsy when they were younger.
This study looks at how people with testicular cancer are doing after finishing treatment. It mainly focuses on follow-up visits (surveillance) and whether you are in remission, which can help doctors understand and improve post-treatment care.
This study looks at long-term health problems and quality of life in people who survived germ cell tumors after strong chemotherapy with a stem cell transplant or other standard treatments. It may help doctors understand which late side effects are most common and how to better support survivors.
Hear when a new Testicular Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.